MedLife reported a consolidated pro-forma turnover of over RON 3.17 billion (approximately €630 million) for 2025, up nearly 17% year-on-year, according to Revista Cariere. Pro-forma EBITDA reached RON 459 million, underscoring the company’s financial resilience in a challenging economic environment.
Since its listing on the Bucharest Stock Exchange in 2016, the company has delivered an average annual growth rate exceeding 20%, reinforcing its position as the leading Romanian-owned private healthcare provider.
Strategic investments drive expansion
Read also: MedLife launches Longevity 100+, the largest genetic testing program in the region
The hospital division recorded a 27% increase in hospitalizations, surpassing 200,000 cases. Laboratories processed more than 10 million tests, while clinics registered nearly 5 million visits. Key demand areas included gynecology, cardiology, advanced imaging (MRI, CT), and minimally invasive surgery.
“Economy is adjusting, and companies feel these changes. Consumption slowed slightly, especially in the last quarter of 2025, yet healthcare remains a constant priority for Romanians. MedLife’s results remained solid, even in a challenging economic context. We believe recent measures are beginning to take effect, and the economy will return to a positive trend.
We look ahead with moderate optimism. The private sector continues to demonstrate resilience: companies work, invest, and actively contribute to the economy, even under difficult conditions.
MedLife remains one of the key pillars of the Romanian economy. The determination of the private sector, combined with a sustainable and predictable framework, is essential for Romania to transform current challenges into long-term growth opportunities,” said Mihai Marcu, CEO & Chairman of the Board, MedLife Group.
In 2025, MedLife expanded its network through acquisitions including MEDSTAR Cluj-Napoca, Routine Med Tulcea, and entry into Moldova via All Clinic. The company also launched its first AI assistant integrated into its app, inaugurated a Center of Excellence in Pelvic Neurosurgery, and opened its first fully automated laboratory in Brașov.
For 2026, MedLife plans to scale its genomic program Longevity 100+, accelerate the integration of AI and robotics, and pursue further acquisitions in complementary areas such as aesthetics, sports, and wellness.
Photo: Medlife
UK
IT
ES
DE
FR
RO
PT
HU
